The clinical impact of Pseudomonas aeruginosa eradication in bronchiectasis in a Dutch referral centre

Eur Respir J. 2019 Apr 11;53(4):1802081. doi: 10.1183/13993003.02081-2018. Print 2019 Apr.

Authors

Angelina Pieters¹, Marleen Bakker², Rogier A S Hoek², Josje Altenburg³, Mireille van Westreenen⁴, Joachim G J V Aerts², Menno M van der Eerden²

Affiliations

¹ Radiology, Twee Steden Ziekenhuis, Tilburg, The Netherlands.
² Dept of Pulmonary Medicine, Erasmus Medical Center, Rotterdam, The Netherlands.
³ Pulmonary Diseases, Amsterdam Medical Center, Amsterdam, The Netherlands.
⁴ Medical Microbiology and Infectious Diseases, Erasmus Medical Center, Rotterdam, The Netherlands.

PMID: 30635292
DOI: 10.1183/13993003.02081-2018

No abstract available

Publication types

Letter

MeSH terms

Adult
Aged
Anti-Bacterial Agents / therapeutic use*
Bronchiectasis / complications*
Bronchiectasis / microbiology*
Cohort Studies
Female
Humans
Male
Middle Aged
Netherlands
Pseudomonas Infections / complications*
Pseudomonas Infections / drug therapy*
Pseudomonas aeruginosa*
Referral and Consultation
Retrospective Studies

Substances

Anti-Bacterial Agents